Nagesh Mahanthappa
Chairman chez Exo Therapeutics, Inc.
Fortune : 8 M $ au 31/03/2024
Provenance du réseau au premier degré de Nagesh Mahanthappa
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
| Public Company | Pharmaceuticals: Major | 27 | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA.
12
| Subsidiary | Biotechnology | 12 |
Abata Therapeutics, Inc.
 Abata Therapeutics, Inc. BiotechnologyHealth Technology Abata Therapeutics, Inc. is a biotech company based in Watertown, MA. Abata Therapeutics is focused on developing engineered Treg cell therapies for severe autoimmune and inflammatory diseases. The American company's lead programs are in ind-enabling studies for progressive multiple sclerosis and type 1 diabetes, both of which are tissue-specific autoimmune diseases with significant unmet needs. The company has developed a differentiated product engine to create tissue-specific, robust, and durable therapies. Abata Therapeutics was launched by Third Rock Ventures, with participation from a diverse syndicate of investors, including ElevateBio, Lightspeed Venture Partners, Invus, Samsara Biocapital, and the JDRF T1D Fund. The company was founded in 2021 by Richard Ransohoff and the CEO is Samantha Singer.
12
| Holding Company | Biotechnology | 12 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States.
8
| Holding Company | Biotechnology | 8 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Casma Therapeutics, Inc.
 Casma Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Casma Therapeutics, Inc. operates biotechnology company harnessing natural cellular process of autophagy to design new medicines. The company was founded by Cary Pfeffer and is headquartered in Cambridge, MA.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Camena Bioscience Ltd.
 Camena Bioscience Ltd. BiotechnologyHealth Technology Camena Bioscience Ltd. is a British biotechnology company that produces long and complex synthetic genes. The company is based in Cambridge, UK. Camena Bioscience was founded in 2016 by Steve Harvey. Steve Harvey has been the CEO since 2016.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Nagesh Mahanthappa via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Human Resources Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel Human Resources Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Investor Relations Contact Corporate Officer/Principal | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GALAPAGOS NV | Biotechnology | Director/Board Member Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Proclara Biosciences, Inc.
 Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director of Finance/CFO | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Undergraduate Degree Graduate Degree Doctorate Degree | |
| Stanford University | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. | Investment Managers | Director/Board Member Corporate Officer/Principal Private Equity Investor | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Operating Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Private Equity Investor | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree | |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| EDITAS MEDICINE, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Founder | |
Jnana Therapeutics, Inc.
 Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer Founder Founder | |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member Chairman | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Founder Chief Operating Officer Corporate Officer/Principal | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Founder Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Consultant / Advisor | |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Flare Therapeutics is a biotechnology company that focuses on drugging transcription factors to develop small molecule medicines. The company is based in Cambridge, MA. The company's integrated discovery engine converges genetic, biochemical, and chemical insights to reveal druggable pockets and identify small molecule ligands capable of modulating transcription factors of high therapeutic potential. Flare's proteomic and mass spectrometry platform is powered by a proprietary library of electrophilic compounds unique to the company. The team has rapidly established an emerging pipeline of programs, highlighted by FX-909, a first-in-class investigational orally bioavailable small molecule inhibitor of PPARG, a master regulator of the luminal lineage in advanced urothelial cancer that has entered the clinic. Flare Therapeutics was launched in 2021 and is backed by founding investor Third Rock Ventures, as well as Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management. The company was founded by Mitchell Lazar, Fraydoon Rastinejad, Robert J. Sims, and Steven L. McKnight. Amit Rakhit has been the CEO of the company since 2022. | Biotechnology | Chairman Director/Board Member Consultant / Advisor |
Statistiques
Internationale
| Etats-Unis | 48 |
| Belgique | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 30 |
| Consumer Services | 13 |
| Finance | 7 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 516 |
| Corporate Officer/Principal | 203 |
| Independent Dir/Board Member | 133 |
| Chairman | 83 |
| Chief Executive Officer | 74 |
Relations les plus connectées
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 54 |
| Amir Nashat | 49 |
| Kristina Burow | 40 |
| John Maraganore | 37 |
| Daniel Lynch | 32 |
| Shelley Chu | 31 |
| Henry Skinner | 29 |
| Vicki Sato | 28 |
| Michael Bigham | 27 |
| Mitchell Finer | 26 |
| Jason Rhodes | 24 |
| John Berriman | 24 |
| Robert Tepper | 24 |
| Abbie Celniker | 23 |
| Kevin Starr | 19 |
- Bourse
- Insiders
- Nagesh Mahanthappa
- Connexions Sociétés
